348 related articles for article (PubMed ID: 25145603)
1. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.
Togawa K; Ma H; Sullivan-Halley J; Neuhouser ML; Imayama I; Baumgartner KB; Smith AW; Alfano CM; McTiernan A; Ballard-Barbash R; Bernstein L
Breast Cancer Res; 2014 Aug; 16(4):414. PubMed ID: 25145603
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women.
Meeske KA; Sullivan-Halley J; Smith AW; McTiernan A; Baumgartner KB; Harlan LC; Bernstein L
Breast Cancer Res Treat; 2009 Jan; 113(2):383-91. PubMed ID: 18297429
[TBL] [Abstract][Full Text] [Related]
4. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
5. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
6. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?
Specht MC; Miller CL; Russell TA; Horick N; Skolny MN; O'Toole JA; Jammallo LS; Niemierko A; Sadek BT; Shenouda MN; Finkelstein DM; Smith BL; Taghian AG
Breast Cancer Res Treat; 2013 Aug; 140(3):485-94. PubMed ID: 23912961
[TBL] [Abstract][Full Text] [Related]
7. Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors.
Das N; Baumgartner RN; Riley EC; Pinkston CM; Yang D; Baumgartner KB
J Cancer Surviv; 2015 Sep; 9(3):422-30. PubMed ID: 25913877
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors.
Paskett ED; Naughton MJ; McCoy TP; Case LD; Abbott JM
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):775-82. PubMed ID: 17416770
[TBL] [Abstract][Full Text] [Related]
10. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
11. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for lymphedema after breast cancer treatment.
Norman SA; Localio AR; Kallan MJ; Weber AL; Torpey HA; Potashnik SL; Miller LT; Fox KR; DeMichele A; Solin LJ
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2734-46. PubMed ID: 20978176
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study.
Ahmed RL; Schmitz KH; Prizment AE; Folsom AR
Breast Cancer Res Treat; 2011 Dec; 130(3):981-91. PubMed ID: 21761159
[TBL] [Abstract][Full Text] [Related]
14. Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?
McDuff SGR; Mina AI; Brunelle CL; Salama L; Warren LEG; Abouegylah M; Swaroop M; Skolny MN; Asdourian M; Gillespie T; Daniell K; Sayegh HE; Naoum GE; Zheng H; Taghian AG
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):62-70. PubMed ID: 30165125
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with breast cancer-related lymphedema in the WHEL Study.
Dominick SA; Madlensky L; Natarajan L; Pierce JP
J Cancer Surviv; 2013 Mar; 7(1):115-23. PubMed ID: 23212606
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
[TBL] [Abstract][Full Text] [Related]
17. Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study.
Miller CL; Colwell AS; Horick N; Skolny MN; Jammallo LS; O'Toole JA; Shenouda MN; Sadek BT; Swaroop MN; Ferguson CM; Smith BL; Specht MC; Taghian AG
Ann Surg; 2016 Feb; 263(2):399-405. PubMed ID: 25607768
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.
Kwan ML; Darbinian J; Schmitz KH; Citron R; Partee P; Kutner SE; Kushi LH
Arch Surg; 2010 Nov; 145(11):1055-63. PubMed ID: 21079093
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up.
Ribeiro Pereira ACP; Koifman RJ; Bergmann A
Breast; 2017 Dec; 36():67-73. PubMed ID: 28992556
[TBL] [Abstract][Full Text] [Related]
20. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.
Swaroop MN; Ferguson CM; Horick NK; Skolny MN; Miller CL; Jammallo LS; Brunelle CL; O'Toole JA; Isakoff SJ; Specht MC; Taghian AG
Breast Cancer Res Treat; 2015 Jun; 151(2):393-403. PubMed ID: 25940996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
